logo
Loading...
3D microfluidic gradient generator for combination antimicrobial susceptibility testing

Medicine and Health

3D microfluidic gradient generator for combination antimicrobial susceptibility testing

E. Sweet, B. Yang, et al.

This groundbreaking research explores the limitations of traditional 2D microfluidic concentration gradient generators in antimicrobial susceptibility testing by introducing a novel 3D-printed microchannel network. The team evaluated the antimicrobial effects of tetracycline, ciprofloxacin, and amikacin against antibiotic-resistant E. coli, paving the way for faster combination AST screening. This innovative platform was developed by authors Eric Sweet, Brenda Yang, Joshua Chen, Reed Vickerman, Yujui Lin, Alison Long, Eric Jacobs, Tinglin Wu, Camille Mercier, Ryan Jew, Yash Attal, Siyang Liu, Andrew Chang, and Liwei Lin.... show more
Abstract
Microfluidic concentration gradient generators (µ-CGGs) have been utilized to identify optimal drug compositions through antimicrobial susceptibility testing (AST) for the treatment of antimicrobial-resistant (AMR) infections. Conventional µ-CGGs fabricated via photolithography-based micromachining processes, however, are fundamentally limited to two-dimensional fluidic routing, such that only two distinct antimicrobial drugs can be tested at once. This work addresses this limitation by employing Multijet-3D-printed microchannel networks capable of fluidic routing in three dimensions to generate symmetric multidrug concentration gradients. The three-fluid gradient generation characteristics of the fabricated 3D µ-CGG prototype were quantified through both theoretical simulations and experimental validations. Furthermore, the antimicrobial effects of three highly clinically relevant antibiotic drugs, tetracycline, ciprofloxacin, and amikacin, were evaluated via experimental single-antibiotic minimum inhibitory concentration (MIC) and pairwise and three-way antibiotic combination drug screening (CDS) studies against model antibiotic-resistant Escherichia coli bacteria. As such, this 3D µ-CGG platform has great potential to enable expedited combination AST screening for various biomedical and diagnostic applications.
Publisher
Microsystems & Nanoengineering
Published On
Oct 27, 2020
Authors
Eric Sweet, Brenda Yang, Joshua Chen, Reed Vickerman, Yujui Lin, Alison Long, Eric Jacobs, Tinglin Wu, Camille Mercier, Ryan Jew, Yash Attal, Siyang Liu, Andrew Chang, Liwei Lin
Tags
microfluidics
antimicrobial susceptibility testing
3D printing
E. coli
multidrug concentration gradients
antibiotic resistance
combination testing
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny